225 related articles for article (PubMed ID: 31498718)
1. Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
Lee OW; Austin S; Gamma M; Cheff DM; Lee TD; Wilson KM; Johnson J; Travers J; Braisted JC; Guha R; Klumpp-Thomas C; Shen M; Hall MD
SLAS Discov; 2020 Jan; 25(1):9-20. PubMed ID: 31498718
[TBL] [Abstract][Full Text] [Related]
2. Predictive models for estimating cytotoxicity on the basis of chemical structures.
Sun H; Wang Y; Cheff DM; Hall MD; Shen M
Bioorg Med Chem; 2020 May; 28(10):115422. PubMed ID: 32234277
[TBL] [Abstract][Full Text] [Related]
3. Cheminformatics approaches to analyze diversity in compound screening libraries.
Akella LB; DeCaprio D
Curr Opin Chem Biol; 2010 Jun; 14(3):325-30. PubMed ID: 20457001
[TBL] [Abstract][Full Text] [Related]
4. High-Throughput Screening and Triage Assays Identify Small Molecules Targeting c-MYC in Cancer Cells.
Kallal LA; Waszkiewicz A; Jaworski JP; Della Pietra A; Berrodin T; Brady P; Jurewicz AJ; Zeng X; Payne L; Medina JR; Doepner-Buser C; Mangatt B
SLAS Discov; 2021 Feb; 26(2):216-229. PubMed ID: 33482073
[TBL] [Abstract][Full Text] [Related]
5. A 1536-Well 3D Viability Assay to Assess the Cytotoxic Effect of Drugs on Spheroids.
Madoux F; Tanner A; Vessels M; Willetts L; Hou S; Scampavia L; Spicer TP
SLAS Discov; 2017 Jun; 22(5):516-524. PubMed ID: 28346088
[TBL] [Abstract][Full Text] [Related]
6. Drug Repurposing Screen Identifies Novel Classes of Drugs with Anticancer Activity in Mantle Cell Lymphoma.
Han C; Yu X; Zhang C; Cai Y; Cao Y; Wang S; Shen J
Comb Chem High Throughput Screen; 2019; 22(7):483-495. PubMed ID: 31526347
[TBL] [Abstract][Full Text] [Related]
7. Computational Toxicology Methods in Chemical Library Design and High-Throughput Screening Hit Validation.
Hevener KE
Methods Mol Biol; 2018; 1800():275-285. PubMed ID: 29934898
[TBL] [Abstract][Full Text] [Related]
8. A chemocentric approach to the identification of cancer targets.
Flachner B; Lörincz Z; Carotti A; Nicolotti O; Kuchipudi P; Remez N; Sanz F; Tóvári J; Szabó MJ; Bertók B; Cseh S; Mestres J; Dormán G
PLoS One; 2012; 7(4):e35582. PubMed ID: 22558171
[TBL] [Abstract][Full Text] [Related]
9. High content screening of defined chemical libraries using normal and glioma-derived neural stem cell lines.
Danovi D; Folarin AA; Baranowski B; Pollard SM
Methods Enzymol; 2012; 506():311-29. PubMed ID: 22341231
[TBL] [Abstract][Full Text] [Related]
10. NCI Program for Natural Product Discovery: A Publicly-Accessible Library of Natural Product Fractions for High-Throughput Screening.
Thornburg CC; Britt JR; Evans JR; Akee RK; Whitt JA; Trinh SK; Harris MJ; Thompson JR; Ewing TL; Shipley SM; Grothaus PG; Newman DJ; Schneider JP; Grkovic T; O'Keefe BR
ACS Chem Biol; 2018 Sep; 13(9):2484-2497. PubMed ID: 29812901
[TBL] [Abstract][Full Text] [Related]
11. Locating sweet spots for screening hits and evaluating pan-assay interference filters from the performance analysis of two lead-like libraries.
Mok NY; Maxe S; Brenk R
J Chem Inf Model; 2013 Mar; 53(3):534-44. PubMed ID: 23451880
[TBL] [Abstract][Full Text] [Related]
12. A 1536-well quantitative high-throughput screen to identify compounds targeting cancer stem cells.
Mathews LA; Keller JM; Goodwin BL; Guha R; Shinn P; Mull R; Thomas CJ; de Kluyver RL; Sayers TJ; Ferrer M
J Biomol Screen; 2012 Oct; 17(9):1231-42. PubMed ID: 22927676
[TBL] [Abstract][Full Text] [Related]
13. An Analysis of Different Components of a High-Throughput Screening Library.
Saha A; Varghese T; Liu A; Allen SJ; Mirzadegan T; Hack MD
J Chem Inf Model; 2018 Oct; 58(10):2057-2068. PubMed ID: 30204440
[TBL] [Abstract][Full Text] [Related]
14. Increasing the delivery of next generation therapeutics from high throughput screening libraries.
Wigglesworth MJ; Murray DC; Blackett CJ; Kossenjans M; Nissink JW
Curr Opin Chem Biol; 2015 Jun; 26():104-10. PubMed ID: 25909818
[TBL] [Abstract][Full Text] [Related]
15. Brief Guide: Experimental Strategies for High-Quality Hit Selection from Small-Molecule Screening Campaigns.
Rothenaigner I; Hadian K
SLAS Discov; 2021 Aug; 26(7):851-854. PubMed ID: 33882754
[TBL] [Abstract][Full Text] [Related]
16. Rapid Discovery of Functional Small Molecule Ligands against Proteomic Targets through Library-Against-Library Screening.
Wu CY; Wang DH; Wang X; Dixon SM; Meng L; Ahadi S; Enter DH; Chen CY; Kato J; Leon LJ; Ramirez LM; Maeda Y; Reis CF; Ribeiro B; Weems B; Kung HJ; Lam KS
ACS Comb Sci; 2016 Jun; 18(6):320-9. PubMed ID: 27053324
[TBL] [Abstract][Full Text] [Related]
17. Repositioning FDA-Approved Drugs in Combination with Epigenetic Drugs to Reprogram Colon Cancer Epigenome.
Raynal NJ; Da Costa EM; Lee JT; Gharibyan V; Ahmed S; Zhang H; Sato T; Malouf GG; Issa JJ
Mol Cancer Ther; 2017 Feb; 16(2):397-407. PubMed ID: 27980103
[TBL] [Abstract][Full Text] [Related]
18. Precision multidimensional assay for high-throughput microRNA drug discovery.
Haefliger B; Prochazka L; Angelici B; Benenson Y
Nat Commun; 2016 Feb; 7():10709. PubMed ID: 26880188
[TBL] [Abstract][Full Text] [Related]
19. Identification of anti-tumour biologics using primary tumour models, 3-D phenotypic screening and image-based multi-parametric profiling.
Sandercock AM; Rust S; Guillard S; Sachsenmeier KF; Holoweckyj N; Hay C; Flynn M; Huang Q; Yan K; Herpers B; Price LS; Soden J; Freeth J; Jermutus L; Hollingsworth R; Minter R
Mol Cancer; 2015 Jul; 14():147. PubMed ID: 26227951
[TBL] [Abstract][Full Text] [Related]
20. A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Lee TD; Lee OW; Brimacombe KR; Chen L; Guha R; Lusvarghi S; Tebase BG; Klumpp-Thomas C; Robey RW; Ambudkar SV; Shen M; Gottesman MM; Hall MD
Mol Pharmacol; 2019 Nov; 96(5):629-640. PubMed ID: 31515284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
